Clinical Trials

1 184 185 186 187
Number of results: 3721

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2011-01-24 GSK’436 advanced or metastatic melanoma with a BRAF V600 mutation 3 GSK (UK) Cancer Oncology
2011-01-24 GSK’212 advanced/metastatic melanoma focuses on patients with BRAF V600 mutation who have had no more than one prior regimen of chemotherapy and no prior BRAF inhibitor treatment 3 GSK (UK) Cancer Oncology
2011-01-20 Erbitux (cetuximab)

KRAS wild-type metastatic colorectal cancer (mCRC)

2 Merck Serono, a Merck KGaA company (Germany) Cancer - Oncology
2011-01-20 zicronapine (Lu 31-130)


3 Lundbeck (Denmark) Mental diseases - CNS diseases
2011-01-19 RG7204 The product is being co-developed under a 2006 license and collaboration agreement between Roche and Plexxikon. BRAF V600 mutation-positive metastatic melanoma. 3 Roche (Switzerland) CancerOncology
2011-01-19 zanamivir influenza 3 GSK (UK) Infectious diseases
2011-01-18 VEGF Trap-Eye (aflibercept ophthalmic solution)

choroidal neovascularisation (CNV) of the retina as a result of pathologic myopia

3 Bayer HealthCare (Germany) Regeneron Pharmaceuticals (USA) Ophtalmology
2011-01-17 talactoferrin severe sepsis 2 Agennix (Germany) Infectious diseases
2011-01-12 MEDI-565 (MT111) advanced gastrointestinal cancer 1 Medimmune (USA) Micromet (USA-Germany) Cancer - Oncology
2011-01-12 Vyvanse® (lisdexamfetamine dimesylate)

Excessive Daytime Sleepiness

Shire (UK-USA) CNS diseases
2011-01-11 biosimilar rituximab rheumatoid arthritis 2 Sandoz (Switzerland) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases
2011-01-10 BC-3781 acute bacterial skin and skin structure infections (ABSSSI) 2 Nabriva Therapeutics (Austria) Infectious diseases
2011-01-07 4SC-203 1 4SC (Germany) Cancer Oncology
2011-01-03 Nalmefene alcohol dependence 3 Lundbeck (Denmark) CNS diseases
2010-11-01 galunisertib (LY2157299) hepatocellular carcinoma 2 Eli Lilly (USA - IN) Cancer - Oncology
2010-10-12 galunisertib glioma 1b-2a Eli Lilly (USA - IN) Cancer - Oncology
2008-03-05 aglatimagene besadenovec (AdV-tk) followed by valacyclovir glioma 1 Advantagene (USA - MA) Cancer - Oncology
2007-12-27 aglatimagene besadenovec (AdV-tk) followed by valacyclovir glioma 2a Advantagene (USA - MA) Cancer - Oncology
0000-00-00 ETS2101 (dexanabinol) Cancer - Oncology
0000-00-00 JNJ-54257099/AL-704 chronic hepatitits C 1 Alios Biopharma, a J&J company (USA - NJ) Janssen Pharmaceutica, a J&J company (USA - NJ) Infectious diseases